*More urgent news not reported by the New York Times, which is too busy
stoking panic,*
*and trying to reconcile us all to staying indoors forever. Of course, it's
possible that someone*
*there—or someone at some other news outlet—is now investigating how and
why Johnson *
*and Johnson got that contract; so **maybe we'll see something on it by and
by. *

*Or maybe not. So please send this far and wide.*

*From John Gilmore, who heads the Autism Action network:*


        The company selected by the federal government to fast-track
develop a coronavirus vaccine is the subject of billions in court
settlements and judgments, in the last year alone, for being a key operator
in the opioid epidemic among other criminal activities, and it has no track
record in creating or manufacturing vaccines. And the federal agency that
issued the contract is part of the same federal department that will
oversee every aspect of the vaccine's evaluation, licensing, and
distribution.

*     Johnson and Johnson (J&J), and it subsidiary Janssen Pharmaceutica,
the enormous global medical products firm, was awarded a $450 million
contract on Monday by the US federal government. J&J will be committing its
own resources to bring the total value of the project to more than $1
billion.  Trials of the vaccine are expected to begin in September and
production for general use is expected to begin in early 2021. Normally
testing and safety analysis of a new vaccine in the US takes 5 to 7 years.
J&J will build a new vaccine factory in the US with a goal of producing a
billion doses annually beginning next year. Yet no vaccine licensed for use
in the US was developed or is manufactured by J&J. And the federal
government is already assuming that the vaccine will be safe and effective.*

*     Expedited development of vaccines in the US has a poor track record.
In 1976 a vaccine was quickly brought to market for an outbreak of swine
flu but just as quickly withdrawn when multiple cases of Guillain Barre
Syndrome were caused. And the H1N1 virus rushed to market in 2009 also
caused significant numbers of Guillain Barre Syndrome among other side
effects.*

*     It is hard to imagine any company could be facing more lawsuits than
J&J. According to the Wall Street journal J&J had 103,000 legal claims by
companies, individuals, states, cities, counties and other legal entities
in the middle of last year. J&J have had legal judgments and settlements of
more than $10 billion just in the previous two years.*

*     Last fall an Oklahoma Court fined J&J $465 million for its role in
the opioid epidemic in that state.  Judge Thad Balkman said J&J had
promulgated "false, misleading, and dangerous marketing campaigns" that had
"caused exponentially increasing rates of addiction, overdose, deaths" and
babies born exposed to opioids. J&J also agreed to a $20 million settlement
for damages associated with opioids in two Ohio counties. Thousands of
other suits are pending across the US.*

*     J&J was a major player contracting with poppy growers in Australia to
supply 60% of the opiate ingredients used for drugs like oxycodone. It also
produced an opioid pill the company sold in 2015, and Duragesic,  a
fentanyl patch.*

*     In a statement released with the announcement of a lawsuit in the
spring of 2019 against J&J and other opioid manufacturers, New York
Attorney General Leticia James said, "We found that pharmaceutical
manufacturers and distributors engaged in years of deceptive marketing
about the risks of opioids and failed to exercise their basic duty to
report suspicious behavior, leading to the crisis we are living with
today."*

*     J&J's legal problems go far beyond opioids. Last month a New Jersey
court ordered J&J to pay $186 million in four cases where plaintiffs
claimed using J&J talcum powder that contained asbestos caused ovarian
cancer. Lawyers for the plaintiffs established that  J&J knew the powder
contained asbestos but denied that fact publicly. The judgment follows
multiple other settlements and awards to plaintiffs including a $4.7
billion judgment by Missouri court in 2018.*

*     J&J also agreed in October of 2019 to a $117 million settlement with
41 states and the District of Columbia over false claims made in the
marketing of a pelvic mesh product. Suits are still outstanding  with  4
other states.*

*     A Philadelphia jury awarded $8 billion in October 2019 to settle
10,000 lawsuits against J&J for side effects, including gynecomastia (males
growing female breasts), associated with its Risperdal product. Risperdal
was licensed as a n anti-psychotic marketed extensively in the early 2000s
to treat "irritability" associated with autism, and was the first drug
licensed to address autism symptoms.*

*     Earlier in 2019 J&J reached a $775 million settlement in 25,000
lawsuits alleging patients were not adequately warned about the risks of
life-threatening complications of their Xarelto blood thinner.  *

*     All safety and efficacy testing for vaccines is performed by the
company seeking to license the product, and then submitted for evaluation
to various agencies within the Federal Department of Health and Human
Services (HHS). The process assumes the applicant will supply accurate
information to the regulatory agencies, yet with J&J the applicant has a
very long and well-established record of deception and lawbreaking.*

*     The process also rests on the assumption that the regulatory agencies
will be a disinterested parties in the outcome of the application process,
yet the federal government is already planning on producing a billion
vaccines within months, and every aspect of the development, evaluation and
marketing of the vaccine will be under the jurisdiction of HHS. The
contract will be administered by the Biological Advanced Research
Development Authority (BARDA), a unit of HHS. Safety and efficacy
evaluation of the new vaccine will be the responsibility of the Food and
Drug Administration (FDA) and the Centers for Disease Control and
Prevention (CDC) which are also units within HHS. The CDC is also the
single largest buyer of vaccines in the US, primarily for the Vaccines for
Children Program. Any injuries that may occur from the use of a vaccine
would be adjudicated by the Health Resources and Services Administration,
which is also a unit within HHS.*

*     Please share this message with friends and family, and please post to
social media while we still can.*



Unsubscribe
<http://cqrcengage.com/achamp/app/subscriptions?r=AAAAC2Flc0NpcGhlcjAx2GR3x2XFTTkpTX8LciJqfLfXsiivkWiQ6YVwC6iqd4A>

[image: Powered by CQRC Engage]
<http://cqrcengage.com/achamp/app/thru?ep=AAAAC2Flc0NpcGhlcjAxziRC7OmTX9q9_TzEUG4iJNwmzbmquD4e0FIEmXLm3QxI0GBOZsmpKnMfae3km24SlpyefjIToeyPF7luMXBeBV_LNvq78nGPE2klD5WN-1Kd2Vv00QH-vN63pDgEGMph&lp=0>

-- 
If you appreciate News From Underground, please consider making a donation — 
either a one-time gift or a monthly subscription: 
http://markcrispinmiller.com/support/
Thank you for your support.

Ways to unsubscribe:
1) send a blank email to [email protected]
PLEASE NOTE: you must unsubscribe using the SAME email with which you subscribed

2) go to http://groups.google.com/group/newsfromunderground and click on the 
"Unsubscribe or change membership" link in the yellow bar at the top of the 
page, then click the "Unsubscribe" button on the next page.

For more News From Underground, visit http://markcrispinmiller.com
--- 
You received this message because you are subscribed to the Google Groups "News 
From Underground" group.
To unsubscribe from this group and stop receiving emails from it, send an email 
to [email protected].
To view this discussion on the web visit 
https://groups.google.com/d/msgid/newsfromunderground/CAGxB6W8cDPbb5yRE521Wb6--aJnFsemcdMtQBQzPNsNaivCu3w%40mail.gmail.com.

Reply via email to